Abstract:AIM: To observe the changes in serum apolipoprotein levels in patients with HBV-related chronic liver disease and to assess the relationship between serum apolipoprotein levels and the degree of liver injury in these patients. METHODS: A total of 113 patients with HBVrelated chronic liver disease were involved in the study, including 33 patients with chronic hepatitis B, 46 patients with liver cirrhosis and 34 patients with liver failure. Patients with liver failure were further subdivided into good prognosis group and poor prognosis group. Fasting serum ApoA1 and ApoB levels were measured and MELD and Child-Pugh scores were calculated in these patients to analyze the correlation between the levels of serum apolipoproteins (including ApoA1, ApoB and ApoA1/B ratio) and liver disease scores (including MELD score and Child-Pugh score). RESULTS: Serum ApoA1 and ApoB levels were highest in the chronic hepatitis B group, followed by the liver cirrhosis group and liver failure group (F = 41.592, P = 0.000; F = 9.178, P = 0.000; ApoA1/B ratio: 1.31 ± 0.73, 1.38 ± 0.65, 0.51 ± 0.38, F = 22.759, P = 0.000). Serum ApoA1 levels and ApoA1/B ratio were not statistically different between the chronic hepatitis B group and liver cirrhosis group (P = 0.057, 0.625), but were significantly lower in the liver failure group than in the other two groups (both P = 0.000). Serum ApoB levels did not differ significantly between patients with liver cirrhosis and those with hepatic failure (P = 0.082), but were significantly lower in the chronic hepatitis B group than in the other two groups (P = 0.006, 0.000). Child-Pugh and MELD scores were lowest in the chronic hepatitis B group, followed by the liver cirrhosis group and liver failure group (F = 74.961, P = 0.000; F = 56.405, P = 0.000). In patients with HBV-related chronic liver disease, serum levels of ApoA1 and ApoB and ApoA1/B ratio were negatively correlated with Child-Pugh and MELD scores (all P < 0.05). In the liver failure group, serum levels of ApoA1 and ApoB, ApoA1/B ratio, Child-Pugh and MELD scores showed no significant difference between the good and poor prognosis groups (all P > 0.05). CONCLUSION: Serum levels of ApoA1, ApoB and ApoA1/ApoB ratio are good parameters to reflect the degree of liver injury in patients with HBV-related chronic liver disease.

Clinical significance of serum angiotensin-converting enzyme changes in patients with liver disease

Clinical Signiifcance of Liver Function in Connective Tissue Disease-related Pulmonary Arterial Hypertension

The Clinical Significance of the Change of Blood-Lipid in Patients with Hepatitis B-related Cirrhosis.

Significance of changes in hepatic histology from patients with HBeAg(+)or HBeAg(-)chronic hepatitis B and normal or mildly elevated alanine aminotransferase

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B

The preliminary discussion of changes of serumγ-GT level in patients with chronic hepatitis B and early liver cirrhosis

Clinical Significance of Alkaline Phosphatase,γ-Glutamyl Transpeptidase and Cholinesterase Detection in Chronic Hepatitis B, Liver Cirrhosis, Hepatocellular Carcinoma and Biliary Tract Disease

Identification and Clinical Significance of an Elevated Level of Serum Aminoacylase-1 Autoantibody in Patients with Hepatitis B Virus-Related Liver Cirrhosis.

Significance of Combined Determination of Five Types of Serum Enzyme in Diagnosis and Differential Diagnosis of Hepatic and Biliary Diseases

Changes of plasma endothelin and angiotensin- Ⅱ in liver cirrhosis and its clinical significance

Clinical Significance of High-Sensitivity C-reactive Protein in Development of Chronic Hepatitis B

Changes and Clinical Significance of Serum Enzyme Levels in Patients with Respiratory Failure

[Liver Histological Changes in Chronic Hepatitis B Patients with Elevated ALT Less Than 2 X ULN].

Detection of serum slL-2R, IL-6, IL-8,TNF-α and lymphocytes subsets, mIL-2R in patients with chronic hepatitis B

Changes of immunoglobulin, sP-selectin and sICAM-1 in patients with different degrees of hepatitis b cirrhosis and the possible clinical significance

Significance of serum apolipoprotein levels in assessing the degree of liver injury in patients with HBVrelated chronic liver disease

Alanine aminotransferase and aspartate aminotransferase levels are sensitive indicators for liver inflammation grading in HBeAg-negative chronic hepatitis B patients

Relationship between genetic polymorphism in angiotensin-converting enzyme,angiotensin Ⅱ type 1 receptor and hepatitis B-related liver cirrhosis

Relationship between the Level of Serum HA,ACTA,TNF-α and the Pathological Changes of the Liver Tissue in Patients with Chronic Hepatitis

The Clinical Significance of Serum Alpha2-Heremans Schmid Glycoprotein in Chronic Severe Hepatitis Patients